Patent Expiry

Patent/Exclusivity Expiry: FILSPARI

Other upcoming events for TVTX

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Parallel-Group Treatment, Blinded, Randomized, Placebo-Controlled Study To Assess The Eff
Phase 3 ReadoutPhase 3 Topline: The University of Ottawa Dapagliflozin in STEMI Randomized Clinical Trial
Phase 3 ReadoutPhase 3 Topline: REVERsal to Normoglycemia by Treating PREDIABETES: The REVERT-PREDIABETES Trial
Phase 3 ReadoutPhase 3 Topline: An Open-Label, Phase 3 Long-Term Extension (LTE) Study To Assess The Safety, Tolerability, And Effic

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: FILSPARI — TVTX Patent Expiry | BioSniper